Heterotypic Amyloid β interactions facilitate amyloid assembly and modify amyloid structure

EMBO J. 2022 Dec 17;41(2):e108591. doi: 10.15252/embj.2021108591. Epub 2021 Nov 29.


It is still unclear why pathological amyloid deposition initiates in specific brain regions or why some cells or tissues are more susceptible than others. Amyloid deposition is determined by the self-assembly of short protein segments called aggregation-prone regions (APRs) that favour cross-β structure. Here, we investigated whether Aβ amyloid assembly can be modified by heterotypic interactions between Aβ APRs and short homologous segments in otherwise unrelated human proteins. Mining existing proteomics data of Aβ plaques from AD patients revealed an enrichment in proteins that harbour such homologous sequences to the Aβ APRs, suggesting heterotypic amyloid interactions may occur in patients. We identified homologous APRs from such proteins and show that they can modify Aβ assembly kinetics, fibril morphology and deposition pattern in vitro. Moreover, we found three of these proteins upon transient expression in an Aβ reporter cell line promote Aβ amyloid aggregation. Strikingly, we did not find a bias towards heterotypic interactions in plaques from AD mouse models where Aβ self-aggregation is observed. Based on these data, we propose that heterotypic APR interactions may play a hitherto unrealized role in amyloid-deposition diseases.

Keywords: Alzheimer’s disease; amyloid beta; heterotypic aggregation; toxicity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amyloid beta-Peptides / chemistry
  • Amyloid beta-Peptides / metabolism*
  • HEK293 Cells
  • Humans
  • Protein Binding
  • Protein Interaction Maps*
  • Protein Multimerization
  • Proteome / chemistry
  • Proteome / metabolism*


  • Amyloid beta-Peptides
  • Proteome